256 related articles for article (PubMed ID: 15385438)
1. Epigenetic loss of the familial tumor-suppressor gene exostosin-1 (EXT1) disrupts heparan sulfate synthesis in cancer cells.
Ropero S; Setien F; Espada J; Fraga MF; Herranz M; Asp J; Benassi MS; Franchi A; Patiño A; Ward LS; Bovee J; Cigudosa JC; Wim W; Esteller M
Hum Mol Genet; 2004 Nov; 13(22):2753-65. PubMed ID: 15385438
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
[TBL] [Abstract][Full Text] [Related]
3. EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma.
Alaminos M; Dávalos V; Ropero S; Setién F; Paz MF; Herranz M; Fraga MF; Mora J; Cheung NK; Gerald WL; Esteller M
Cancer Res; 2005 Apr; 65(7):2565-71. PubMed ID: 15805250
[TBL] [Abstract][Full Text] [Related]
4. Methylation status of EXT1 and EXT2 promoters and two mutations of EXT2 in chondrosarcoma.
Tsuchiya T; Osanai T; Ogose A; Tamura G; Chano T; Kaneko Y; Ishikawa A; Orui H; Wada T; Ikeda T; Namba M; Takigawa M; Kawashima H; Hotta T; Tsuchiya A; Ogino T; Motoyama T
Cancer Genet Cytogenet; 2005 Apr; 158(2):148-55. PubMed ID: 15796962
[TBL] [Abstract][Full Text] [Related]
5. The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate.
McCormick C; Leduc Y; Martindale D; Mattison K; Esford LE; Dyer AP; Tufaro F
Nat Genet; 1998 Jun; 19(2):158-61. PubMed ID: 9620772
[TBL] [Abstract][Full Text] [Related]
6. Biosynthesis of heparan sulfate in EXT1-deficient cells.
Okada M; Nadanaka S; Shoji N; Tamura J; Kitagawa H
Biochem J; 2010 May; 428(3):463-71. PubMed ID: 20377530
[TBL] [Abstract][Full Text] [Related]
7. Identification and functional characterization of the human EXT1 promoter region.
Jennes I; Zuntini M; Mees K; Palagani A; Pedrini E; De Cock G; Fransen E; Vanden Berghe W; Sangiorgi L; Wuyts W
Gene; 2012 Jan; 492(1):148-59. PubMed ID: 22037484
[TBL] [Abstract][Full Text] [Related]
8. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
[TBL] [Abstract][Full Text] [Related]
9. A mouse skin multistage carcinogenesis model reflects the aberrant DNA methylation patterns of human tumors.
Fraga MF; Herranz M; Espada J; Ballestar E; Paz MF; Ropero S; Erkek E; Bozdogan O; Peinado H; Niveleau A; Mao JH; Balmain A; Cano A; Esteller M
Cancer Res; 2004 Aug; 64(16):5527-34. PubMed ID: 15313885
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer.
Agrelo R; Cheng WH; Setien F; Ropero S; Espada J; Fraga MF; Herranz M; Paz MF; Sanchez-Cespedes M; Artiga MJ; Guerrero D; Castells A; von Kobbe C; Bohr VA; Esteller M
Proc Natl Acad Sci U S A; 2006 Jun; 103(23):8822-7. PubMed ID: 16723399
[TBL] [Abstract][Full Text] [Related]
11. Decreased EXT expression and intracellular accumulation of heparan sulphate proteoglycan in osteochondromas and peripheral chondrosarcomas.
Hameetman L; David G; Yavas A; White SJ; Taminiau AH; Cleton-Jansen AM; Hogendoorn PC; Bovée JV
J Pathol; 2007 Mar; 211(4):399-409. PubMed ID: 17226760
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies.
Taniguchi H; Fernández AF; Setién F; Ropero S; Ballestar E; Villanueva A; Yamamoto H; Imai K; Shinomura Y; Esteller M
Cancer Res; 2009 Nov; 69(21):8447-54. PubMed ID: 19861541
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic inactivation of the candidate tumor suppressor gene HOXB13 in human renal cell carcinoma.
Okuda H; Toyota M; Ishida W; Furihata M; Tsuchiya M; Kamada M; Tokino T; Shuin T
Oncogene; 2006 Mar; 25(12):1733-42. PubMed ID: 16278676
[TBL] [Abstract][Full Text] [Related]
14. EXTL3 promoter methylation down-regulates EXTL3 and heparan sulphate expression in mucinous colorectal cancers.
Karibe T; Fukui H; Sekikawa A; Shiratori K; Fujimori T
J Pathol; 2008 Sep; 216(1):32-42. PubMed ID: 18543267
[TBL] [Abstract][Full Text] [Related]
15. Promoter methylation-mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance.
Narayan G; Freddy AJ; Xie D; Liyanage H; Clark L; Kisselev S; Un Kang J; Nandula SV; McGuinn C; Subramaniyam S; Alobeid B; Satwani P; Savage D; Bhagat G; Murty VV
Genes Chromosomes Cancer; 2011 Dec; 50(12):1043-53. PubMed ID: 21960365
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
[TBL] [Abstract][Full Text] [Related]
17. The role of EXT1 in nonhereditary osteochondroma: identification of homozygous deletions.
Hameetman L; Szuhai K; Yavas A; Knijnenburg J; van Duin M; van Dekken H; Taminiau AH; Cleton-Jansen AM; Bovée JV; Hogendoorn PC
J Natl Cancer Inst; 2007 Mar; 99(5):396-406. PubMed ID: 17341731
[TBL] [Abstract][Full Text] [Related]
18. Differentiation-induced loss of heparan sulfate in human exostosis derived chondrocytes.
Hecht JT; Hayes E; Haynes R; Cole WG; Long RJ; Farach-Carson MC; Carson DD
Differentiation; 2005 Jun; 73(5):212-21. PubMed ID: 16026543
[TBL] [Abstract][Full Text] [Related]
19. ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation.
Takada H; Imoto I; Tsuda H; Nakanishi Y; Ichikura T; Mochizuki H; Mitsufuji S; Hosoda F; Hirohashi S; Ohki M; Inazawa J
Oncogene; 2005 Dec; 24(54):8051-60. PubMed ID: 16103878
[TBL] [Abstract][Full Text] [Related]
20. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]